Literature DB >> 24227794

Resident microbiota affect Bordetella pertussis infectious dose and host specificity.

Laura S Weyrich1, Heather A Feaga, Jihye Park, Sarah J Muse, Chetan Y Safi, Olivier Y Rolin, Sarah E Young, Eric T Harvill.   

Abstract

Before contacting host tissues, invading pathogens directly or indirectly interact with host microbiota, but the effects of such interactions on the initial stages of infection are poorly understood. Bordetella pertussis is highly infectious among humans but requires large doses to colonize rodents, unlike a closely related zoonotic pathogen, Bordetella bronchiseptica, raising important questions about the contributions of bacterial competition to initial colonization and host selection. We observed that <100 colony-forming units (CFU) of B. bronchiseptica efficiently infected mice and displaced culturable host microbiota, whereas 10 000 CFU of B. pertussis were required to colonize murine nasal cavities and did not displace host microorganisms. Bacteria isolated from murine nasal cavities but not those from the human lower respiratory tract limited B. pertussis growth in vitro, indicating that interspecies competition may limit B. pertussis colonization of mice. Further, a broad-spectrum antibiotic treatment delivered before B. pertussis inoculation reduced the infectious dose to <100 CFU, and reintroduction of single Staphylococcus or Klebsiella species was sufficient to inhibit B. pertussis colonization of antibiotic-treated mice. Together, these results reveal that resident microorganisms can prevent B. pertussis colonization and influence host specificity, and they provide rationale for manipulating microbiomes to create more-accurate animal models of infectious diseases.

Entities:  

Keywords:  Bordetella; antibiotics; bacterial competition; host adaptation; interspecies competition; microbiome; pathogen evolution; whooping cough

Mesh:

Substances:

Year:  2013        PMID: 24227794      PMCID: PMC3935476          DOI: 10.1093/infdis/jit597

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  45 in total

Review 1.  Mechanisms of Bordetella pathogenesis.

Authors:  S Mattoo; A K Foreman-Wykert; P A Cotter; J F Miller
Journal:  Front Biosci       Date:  2001-11-01

2.  Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica.

Authors:  Julian Parkhill; Mohammed Sebaihia; Andrew Preston; Lee D Murphy; Nicholas Thomson; David E Harris; Matthew T G Holden; Carol M Churcher; Stephen D Bentley; Karen L Mungall; Ana M Cerdeño-Tárraga; Louise Temple; Keith James; Barbara Harris; Michael A Quail; Mark Achtman; Rebecca Atkin; Steven Baker; David Basham; Nathalie Bason; Inna Cherevach; Tracey Chillingworth; Matthew Collins; Anne Cronin; Paul Davis; Jonathan Doggett; Theresa Feltwell; Arlette Goble; Nancy Hamlin; Heidi Hauser; Simon Holroyd; Kay Jagels; Sampsa Leather; Sharon Moule; Halina Norberczak; Susan O'Neil; Doug Ormond; Claire Price; Ester Rabbinowitsch; Simon Rutter; Mandy Sanders; David Saunders; Katherine Seeger; Sarah Sharp; Mark Simmonds; Jason Skelton; Robert Squares; Steven Squares; Kim Stevens; Louise Unwin; Sally Whitehead; Bart G Barrell; Duncan J Maskell
Journal:  Nat Genet       Date:  2003-08-10       Impact factor: 38.330

3.  Subcellular localization and immunological detection of proteins encoded by the vir locus of Bordetella pertussis.

Authors:  S Stibitz; M S Yang
Journal:  J Bacteriol       Date:  1991-07       Impact factor: 3.490

4.  Contact-dependent inhibition of growth in Escherichia coli.

Authors:  Stephanie K Aoki; Rupinderjit Pamma; Aaron D Hernday; Jessica E Bickham; Bruce A Braaten; David A Low
Journal:  Science       Date:  2005-08-19       Impact factor: 47.728

5.  The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance.

Authors:  Mylisa R Pilione; Eric T Harvill
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

6.  Delayed role of tumor necrosis factor- alpha in overcoming the effects of pertussis toxin.

Authors:  Daniel N Wolfe; Paul B Mann; Anne M Buboltz; Eric T Harvill
Journal:  J Infect Dis       Date:  2007-09-12       Impact factor: 5.226

Review 7.  Epidemiology of pertussis.

Authors:  Tina Tan; Evelinda Trindade; Danuta Skowronski
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

8.  The opportunistic pathogen Serratia marcescens utilizes type VI secretion to target bacterial competitors.

Authors:  Sarah L Murdoch; Katharina Trunk; Grant English; Maximilian J Fritsch; Ehsan Pourkarimi; Sarah J Coulthurst
Journal:  J Bacteriol       Date:  2011-09-02       Impact factor: 3.490

9.  BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model.

Authors:  P A Cotter; J F Miller
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing.

Authors:  Ulrich Heininger; Peggy A Cotter; Howard W Fescemyer; Guillermo Martinez de Tejada; Ming H Yuk; Jeff F Miller; Eric T Harvill
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  23 in total

Review 1.  Mechanisms of Bacterial Colonization of the Respiratory Tract.

Authors:  Steven J Siegel; Jeffrey N Weiser
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

2.  Interspecies variations in Bordetella catecholamine receptor gene regulation and function.

Authors:  Timothy J Brickman; Ryan J Suhadolc; Sandra K Armstrong
Journal:  Infect Immun       Date:  2015-09-14       Impact factor: 3.441

Review 3.  Integrative Physiology of Pneumonia.

Authors:  Lee J Quinton; Allan J Walkey; Joseph P Mizgerd
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

4.  Alien vs. predator: bacterial challenge alters coral microbiomes unless controlled by Halobacteriovorax predators.

Authors:  Rory M Welsh; Rebecca L Vega Thurber; Stephanie M Rosales; Jesse R Zaneveld; Jérôme P Payet; Ryan McMinds; Steven L Hubbs
Journal:  PeerJ       Date:  2017-05-31       Impact factor: 2.984

5.  Development of the tonsillar microbiome in pigs from newborn through weaning.

Authors:  Luis Carlos Pena Cortes; Rhiannon M LeVeque; Julie Funk; Terence L Marsh; Martha H Mulks
Journal:  BMC Microbiol       Date:  2018-04-16       Impact factor: 3.605

6.  Commensal Microbes Affect Host Humoral Immunity to Bordetella pertussis Infection.

Authors:  Youyi Zhang; Zihan Ran; Miaomiao Tian; Yang Zhou; Jingcheng Yang; Juan Yin; Daru Lu; Rui Li; Jiang Zhong
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

7.  Vaccine-Mediated Activation of Human TLR4 Is Affected by Modulation of Culture Conditions during Whole-Cell Pertussis Vaccine Preparation.

Authors:  Marieke E Hoonakker; Lisa M Verhagen; Elder Pupo; Alex de Haan; Bernard Metz; Coenraad F M Hendriksen; Wanda G H Han; Arjen Sloots
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

Review 8.  Modelling upper respiratory tract diseases: getting grips on host-microbe interactions in chronic rhinosinusitis using in vitro technologies.

Authors:  Charlotte De Rudder; Marta Calatayud Arroyo; Sarah Lebeer; Tom Van de Wiele
Journal:  Microbiome       Date:  2018-04-24       Impact factor: 14.650

9.  Development of the Tonsil Microbiome in Pigs and Effects of Stress on the Microbiome.

Authors:  Luis Carlos Pena Cortes; Rhiannon M LeVeque; Julie A Funk; Terence L Marsh; Martha H Mulks
Journal:  Front Vet Sci       Date:  2018-09-19

10.  Blood or Serum Exposure Induce Global Transcriptional Changes, Altered Antigenic Profile, and Increased Cytotoxicity by Classical Bordetellae.

Authors:  Monica C Gestal; Israel Rivera; Laura K Howard; Kalyan K Dewan; Illiassou Hamidou Soumana; Margaret Dedloff; Tracy L Nicholson; Bodo Linz; Eric T Harvill
Journal:  Front Microbiol       Date:  2018-09-07       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.